SYSCHEM (INDIA)
Back to Cashflow Statement
|
SYSCHEM (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹34 Cr | ₹32 Cr | ₹11 Cr | ₹-0.28 Cr | ₹-0.06 Cr |
What is the latest Cash Flow from Financing Activities ratio of SYSCHEM (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹-0.28 Cr |
| Mar2021 | ₹-0.06 Cr |
How is Cash Flow from Financing Activities of SYSCHEM (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 6.85 | |
| Mar2024 | ₹32 Cr | 196.01 | |
| Mar2023 | ₹11 Cr | Positive | |
| Mar2022 | ₹-0.28 Cr | Negative | |
| Mar2021 | ₹-0.06 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹250.1 Cr | 6.6% | 1.3% | 22.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | 6.6% |
1.3% |
22.2% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses